IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v16y2019i13p2368-d245470.html
   My bibliography  Save this article

Cost–Benefit Analysis of Real-Time Influenza Testing for Patients in German Emergency Rooms

Author

Listed:
  • Roland Diel

    (Institute for Epidemiology, University Medical Hospital Schleswig-Holstein, Kiel, Airway Research Center North (ARCN), 24015 Kiel, Germany
    Lung Clinic Grosshansdorf, Germany. Airway Disease Center North (ARCN), German Center for Lung Research (DZL), 22949 Großhansdorf, Germany
    Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services (BGW), 22089 Hamburg, Germany)

  • Albert Nienhaus

    (Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services (BGW), 22089 Hamburg, Germany
    Institute for Health Service Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany)

Abstract

Background: Seasonal influenza causes significant morbidity worldwide and has a substantial economic impact on the healthcare system. Objective: To assess the cost–benefit relation of implementing a real-time influenza test in emergency rooms (ER) of German hospitals. Methods: A deterministic decision-analytic model was developed simulating the incremental costs of using the Solana ® Influenza A+B test, compared to those of using conventional clinical judgement alone to confirm or exclude influenza in adult ILI (influenza-like illness) patients, in German ER, prior to hospitalization. Direct costs were evaluated from the hospital perspective, considering resource use directly related to influenza testing and treatment, as well as indirect costs incurred by nosocomial influenza transmission. Results: Through base-case analysis and assuming an influenza prevalence of 42.6%, real-time testing with Solana ® reduced average costs of hospitalized ILI patients by €132.61, per tested patient. Moreover, the Solana ® saved €6.9 per tested patient in favor of the hospital. In probabilistic sensitivity analysis, under all reasonable assumptions, implementing the Solana ® saved on average €144.13 as compared to applying the clinical-judgement-only strategy, thus, it was found to be constantly less expensive. Conclusions: Using highly sensitive and specific real-time influenza tests in ILI patients at German ER might significantly reduce hospital expenditures

Suggested Citation

  • Roland Diel & Albert Nienhaus, 2019. "Cost–Benefit Analysis of Real-Time Influenza Testing for Patients in German Emergency Rooms," IJERPH, MDPI, vol. 16(13), pages 1-16, July.
    • Handle: RePEc:gam:jijerp:v:16:y:2019:i:13:p:2368-:d:245470
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/16/13/2368/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/16/13/2368/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Maria Michela Gianino & Gianfranco Politano & Antonio Scarmozzino & Michela Stillo & Viola Amprino & Stefano Di Carlo & Alfredo Benso & Carla Maria Zotti, 2019. "Cost of Sickness Absenteeism during Seasonal Influenza Outbreaks of Medium Intensity among Health Care Workers," IJERPH, MDPI, vol. 16(5), pages 1-11, March.
    2. Matthias Vogl, 2012. "Assessing DRG cost accounting with respect to resource allocation and tariff calculation: the case of Germany," Health Economics Review, Springer, vol. 2(1), pages 1-12, December.
    3. Jennifer Haas & Sebastian Braun & Peter Wutzler, 2016. "Burden of influenza in Germany: a retrospective claims database analysis for the influenza season 2012/2013," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(6), pages 669-679, July.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Yuan Jiang & Ye-qing Tong & Bin Fang & Wen-kang Zhang & Xue-jie Yu, 2022. "Applying the Moving Epidemic Method to Establish the Influenza Epidemic Thresholds and Intensity Levels for Age-Specific Groups in Hubei Province, China," IJERPH, MDPI, vol. 19(3), pages 1-16, February.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Rieka von der Warth & Philip Hehn & Jan Wolff & Klaus Kaier, 2020. "Hospital costs associated with post-traumatic stress disorder in somatic patients: a retrospective study," Health Economics Review, Springer, vol. 10(1), pages 1-8, December.
    2. Carlo Federici & Marianna Cavazza & Francesco Costa & Claudio Jommi, 2018. "Health care costs of influenza-related episodes in high income countries: A systematic review," PLOS ONE, Public Library of Science, vol. 13(9), pages 1-15, September.
    3. repec:mea:meawpa:13272 is not listed on IDEAS
    4. Robert Susło & Piotr Pobrotyn & Lidia Brydak & Łukasz Rypicz & Urszula Grata-Borkowska & Jarosław Drobnik, 2021. "Seasonal Influenza and Low Flu Vaccination Coverage as Important Factors Modifying the Costs and Availability of Hospital Services in Poland: A Retrospective Comparative Study," IJERPH, MDPI, vol. 18(10), pages 1-15, May.
    5. Klaus Kaier & Holger Reinecke & Huseyin Naci & Lutz Frankenstein & Martin Bode & Werner Vach & Philip Hehn & Andreas Zirlik & Manfred Zehender & Jochen Reinöhl, 2018. "The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(2), pages 223-228, March.
    6. Vogl, Matthias, 2014. "Hospital financing: Calculating inpatient capital costs in Germany with a comparative view on operating costs and the English costing scheme," Health Policy, Elsevier, vol. 115(2), pages 141-151.
    7. Sierk D. Marbus & Valentijn A. Schweitzer & Geert H. Groeneveld & Jan J. Oosterheert & Peter M. Schneeberger & Wim Hoek & Jaap T. Dissel & Arianne B. Gageldonk-Lafeber & Marie-Josée Mangen, 2020. "Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(5), pages 775-785, July.
    8. Jürges, Hendrik & Köberlein, Juliane, 2015. "What explains DRG upcoding in neonatology? The roles of financial incentives and infant health," Journal of Health Economics, Elsevier, vol. 43(C), pages 13-26.
    9. Klaus Kaier & Constantin Mühlen & Andreas Zirlik & Wolfgang Bothe & Philip Hehn & Manfred Zehender & Christoph Bode & Peter Stachon, 2019. "Estimating the additional costs per life saved due to transcatheter aortic valve replacement: a secondary data analysis of electronic health records in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(4), pages 625-632, June.
    10. Christoph Baltin & Florian Kron & Alexander Urbanski & Thomas Zander & Anna Kron & Felix Berlth & Robert Kleinert & Michael Hallek & Arnulf Heinrich Hoelscher & Seung-Hun Chon, 2019. "The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomy," PLOS ONE, Public Library of Science, vol. 14(8), pages 1-12, August.
    11. Boes, Stefan & Napierala, Christoph, 2021. "Assessment of the introduction of DRG-based reimbursement in Switzerland: Evidence on the short-term effects on length of stay compliance in university hospitals," Health Policy, Elsevier, vol. 125(6), pages 739-750.
    12. Henri Teittinen & Janina Männikkö, 2022. "Case-Mix Accounting System Design in Social and Health Care Sector - The Mechanisms of Hybridization," European Financial and Accounting Journal, Prague University of Economics and Business, vol. 2022(3), pages 49-69.
    13. Roland Diel & Albert Nienhaus, 2023. "Cost–Benefit of Real-Time Multiplex PCR Testing of SARS-CoV-2 in German Hospitals," IJERPH, MDPI, vol. 20(4), pages 1-12, February.
    14. Hendrik Jürges & Juliane Köberlein, 2013. "First Do No Harm. Then Do Not Cheat: DRG Upcoding in German Neonatology," Discussion Papers of DIW Berlin 1314, DIW Berlin, German Institute for Economic Research.
    15. Isabel C. P. Marques & Maria-Ceu Alves, 2023. "Hospital Costing Methods: Four Decades of Literature Review," JRFM, MDPI, vol. 16(10), pages 1-22, October.
    16. Mercè Soler-Font & Ignacio Aznar-Lou & Luca Basile & Núria Soldevila & Pere Godoy & Ana Martínez & Antoni Serrano-Blanco & Angela Domínguez & The Surveillance of Hospitalized Cases of Severe Influenza, 2022. "Costs and Factors Associated with Hospitalizations Due to Severe Influenza in Catalonia (2017–2020)," IJERPH, MDPI, vol. 19(22), pages 1-10, November.
    17. Ioanna Avakian & Katerina Dadouli & Lemonia Anagnostopoulos & Konstantinos Fotiadis & Athanasios Lianos & Paraskevi Mina & Christos Hadjichristodoulou & Varvara A. Mouchtouri, 2023. "Nationwide Survey on Seasonal Influenza Vaccination among Health Care Workers during the COVID-19 Pandemic in Greece: Determinants, Barriers and Peculiarities," IJERPH, MDPI, vol. 20(13), pages 1-13, June.
    18. Klaus Kaier & Martin Wolkewitz & Philip Hehn & Nico T. Mutters & Thomas Heister, 2020. "The impact of hospital-acquired infections on the patient-level reimbursement-cost relationship in a DRG-based hospital payment system," International Journal of Health Economics and Management, Springer, vol. 20(1), pages 1-11, March.
    19. Irma Convertino & Stefano Salvadori & Alessandro Pecori & Maria Teresa Galiulo & Sara Ferraro & Maria Parrilli & Tiberio Corona & Giuseppe Turchetti & Corrado Blandizzi & Marco Tuccori, 2019. "Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis," Drug Safety, Springer, vol. 42(3), pages 427-444, March.
    20. Xidong Guo, 2024. "An analysis of a rural hospital's investment decision under different payment systems," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 714-747, April.
    21. Malgorzata Cyganska & Piotr Cyganski & Chris Pyke, 2019. "Development of clinical value unit method for calculating patient costs," Health Economics, John Wiley & Sons, Ltd., vol. 28(8), pages 971-983, August.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:16:y:2019:i:13:p:2368-:d:245470. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.